How we work with experts
Every two years, the Index methodology is refined based on a targeted review of how stakeholders view pharma’s role in access to medicine. Find out more about the review process and how experts get involved.
We work every day to change how pharmaceutical companies bring their medicines to the poor. In addition to our in-house Foundation team, we are supported by formal committees of independent experts and reviewers. The strategic supervision of the Access to Medicine Foundation is in the hands of its Supervisory Board.
The Methodology for the 2021 Access to Medicine Index
The methodology for the next Access to Medicine Index captures the priority areas for pharmaceutical companies to advance access to medicine, amidst international calls for sustained action to achieve the Sustainable Development Goals and universal health coverage by 2030. Developed through the Access to Medicine Foundation’s consensus-building process, these priorities have been distilled into a new, tighter analytical framework for 2021.